Floatz logo

Nusinersen

Tremor

University Medical Centre Ljubljananucleic_acidDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Tremor cohort.

Asset / SponsorPhaseRating
Istradefylline
Georgetown University
Phase 4BB
Xeomin®
Melbourne Health
Phase 3B
INCOBOTULINUMTOXINA
Yale University
Phase 2B
Suvecaltamide
Jazz Pharmaceuticals
Phase 2B
cx-8998
Jazz Pharmaceuticals
Phase 2CCC

View all 10 →

Same molecule, other indications

Nusinersen is also rated in:

spinal muscular atrophyDormant
A
Indicative ·
82 / 100
View asset →
spinal muscular atrophy, type IIDormant
CCC
Indicative ·
53 / 100
View asset →
spinal muscular atrophy, type IIIDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →